Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
Henry Ford Health System, Detroit, Michigan, United States
Health Ford Health System, Detroit, Michigan, United States
The Ottawa Hospital, Ottawa, Ontario, Canada
St. Joseph's Hamilton Healthcare, Hamilton, Ontario, Canada
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada
Saint George Hospital University Medical Center, Beirut, Lebanon
Neurosanatio s.r.o., Litomyšl, 570 01, Czechia
Cerebrovaskulární poradna, s.r.o., Ostrava - Poruba, 70800, Czechia
Nemocnice Pardubického kraje a.s. Pardubická nemocnice Neurologická klinika, Pardubice, 532 03, Czechia
AZ Groeninge, Kortrijk, West-Vlaanderen, Belgium
UZ Ghent, Gent, Oost-Vlaanderen, Belgium
Edmonton General Continuing Care Centre, Edmonton, Canada
Royal Alexandra Hospital, Edmonton, Canada
Grey Nuns Community Hospital, Edmonton, Canada
UC Davis Medical Center, Sacramento, California, United States
Planned Parenthood, Washington, District of Columbia, United States
MedStar Washington Hospital Center, Washington, District of Columbia, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.